First Round of Companies to Present at AdvaMed 2008 Selected

Tuesday, July 29, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

Innovative and High Growth Companies to Speak; 2nd Selection Round Begins July 31st

WASHINGTON, July 28 /PRNewswire-USNewswire/ -- The first round of presenting companies have been selected for the September 21-24 AdvaMed 2008 MedTech conference. Company presentations offer U.S. and international medical technology innovators and market leaders with a unique business development and information sharing opportunity.

In this initial round, 37 companies have been selected to present to an elite audience of potential investors, strategic partners, and business collaborators at AdvaMed 2008. Company presentations are organized into a number of categories including: Cardiovascular, Dental, Diagnostics, Imaging, Metabolic Disease/Obesity, Neurology, Ophthalmology, Orthopedics/Spine, Wound Care, Next Generation, and other topics. Applications for round two selections are available online at and the deadline to apply is July 30, 2008.

Companies were selected by a committee of leading business development and licensing executives, venture capitalists, bankers, company CEOs, and other industry experts. To showcase medical technologies earlier in the product development cycle, AdvaMed 2008 will feature a new "Next Generation" presentation group. These companies have either been formed in the last three years or are currently in pre-clinical/pilot trial development.

Of the initial 37 companies, 14 start-ups were selected to give 8-minute presentations in the "Next Generation" group, including:

-- 20/20 GeneSystems of Rockville, Maryland

-- Apeliotus Vision Science of Atlanta, Georgia

-- BioMarker Strategies of Baltimore Maryland

-- Chemica Technologies, Inc. of Beaverton, Oregon

-- eSight Corporation of Ottawa, Canada

-- Mesynthes of Wellington, New Zealand

-- Muve of Wayzata, Minnesota

-- Therapeutic Monitoring Systems, Inc. of Ottawa, Canada

-- Urovalve, Inc of Newark, New Jersey

-- Veralight of San Ramon, California

-- Xylos Corporation of Langhorne, Pennsylvania

Companies selected to make 14-minute presentations at AdvaMed 2008 include:

-- AcryMed of Beaverton, Oregon

-- Allegro Diagnostics, Inc. of Boston, Massachusetts

-- Axial Biotech of Salt Lake City, Utah

-- BD of Franklin Lakes, New Jersey

-- BioControl Medical of Yehud, Israel

-- BoneGrafix, Inc. of Rockville, Maryland

-- Cohera Medical of Pittsburgh, Pennsylvania

-- Critical Care Innovations, Inc. of Fairfax, Virginia

-- Deltex Medical of Chichester, United Kingdom

-- DermTech of San Diego, California

-- Endovalve Inc. of Princeton, New Jersey

-- ISTO Technologies, Inc. of St. Louis, Missouri

-- Ivivi Technologies of Montvale, New Jersey

-- MagForce Nanotechnologies AG of Berlin, Germany

-- MicroPhage, Inc. of Longmont, Colorado

-- mNemoscience GmbH of Aachen, Germany

-- Nanomix, Inc of Emeryville, California

-- Nerites Corporation of Madison, Wisconsin

-- Neuronetics, Inc of Malvern, Pennsylvania

-- Nitric BioTherapeutics, Inc of Bristol, Pennsylvania

-- OrSense of Nes Ziona, Israel

-- PEAK Surgical, Inc. of Palo Alto, California

-- ProDrive Systems of Montreal, Canada

-- Quidel Corporation of San Diego, California

-- Seno Medical Instruments, Inc. of San Antonio, Texas

-- SyntheMed, Inc. of Iselin, New Jersey

Specific time slots and locations of presentations will be announced in early September.

For more information about AdvaMed 2008, visit, call (202) 434-7213, or e-mail Questions speci

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store